Physician
Zain Medical Center
Zain Medical Center was paid $1.68M by Medicaid between Jan 2018 and Dec 2020, across 33 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 30% of everything it billed.
33Billing provider infoZAIN MEDICAL CENTER
RICHLAND, WA 99352
RICHLAND, WA 99352
33aNPI1427416437assigned 02/04/2016
33bProvider typeObstetrics & Gynecology Physician
28Total paid$1.68M
24GClaims45,784
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2020
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Washington
Rank by total paid#3 of 54
Median peer was paid$22K
This provider vs. median77×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,015 | $609K | |
| 2019 | 16,958 | $681K | |
| 2020 | 14,811 | $389K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 30% | 8,982 | 5,750 | $506K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 21% | 2,711 | 1,902 | $348K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 10,601 | 7,106 | $312K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 6,105 | 4,836 | $259K |
| 99354 | 7.3% | 2,543 | 1,536 | $123K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5.4% | 927 | 655 | $90K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 356 | 353 | $23K |
| 96127 | <1% | 1,557 | 1,206 | $5K | |
| 81025 | <1% | 452 | 325 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 77 | 69 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 112 | 108 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 62 | 62 | $1K |
21 more codes
| 80061 | Lipid panel | <1% | 92 | $847.56 |
| 80053 | Comprehensive metabolic panel | <1% | 118 | $783.23 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 39 | $781.44 |
| 90756 | <1% | 44 | $752.07 | |
| 99050 | <1% | 120 | $727.86 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 108 | $725.84 |
| 83527 | <1% | 53 | $386.40 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | $192.59 |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 16 | $171.88 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 36 | $165.86 |
| 83525 | <1% | 17 | $159.18 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 76 | $147.82 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 24 | $145.32 |
| 80305 | <1% | 14 | $75.95 | |
| 3085F | <1% | 20 | $75.00 | |
| 72100 | <1% | 20 | $59.54 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 41 | $4.83 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 926 | $0.00 |
| 99072 | 0% | 277 | $0.00 | |
| 1170F | 0% | 4,578 | $0.00 | |
| 1125F | 0% | 4,661 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANWAR, SAMI (CEO)